Aptar Pharma

Aptar Pharma launches metal-free nasal spray pump

The APF Futurity nasal spray pump. [Image courtesy of Aptar Pharma]Aptar Pharma announced today that it launched its first metal-free, multidose nasal spray pump, called the APF Futurity.

Crystal Lake, Illinois-based Aptar developed APF Futurity to deliver nasal saline and other comparable over-the-counter (OTC) formulations. The company designed the pump specifically for recyclability.

Get the full story at our sister site, Drug Delivery Business News.

FDA approves first nasally administered pharmaceutical treatment for dry eye

[Image from Aptar Pharma]AptarGroup (NYSE:ATR) announced today that it received FDA approval for its nasal pump to deliver a pharmaceutical treatment for dry eye.

Crystal Lake, Illinois-based Aptar’s patented Cartridge Pump System (CPS), designed for the multidose delivery of preserved and non-preserved drug formulations, received approval as the device for delivering Oyster Point Pharma’s Tyrvaya (varenicline solution) nasal spray (0.03 mg).

Get the full story at our sister site, Drug Delivery Business News.